Abacus Medicine A/S reported earnings results for the first quarter of 2019. For the quarter, total revenue was EUR 90.4 million compared to EUR 71.8 million for the same period in 2018.

For the 2019 fiscal year, Abacus Medicine expects revenue growth compared to fiscal year 2018 to be in the range of 20% to 35%, which corresponds to revenues between EUR 400 and EUR 445 million.